{"lastClose": 6.949999809265137, "len": 1073, "date": "2023-01-17", "alpha_1": -0.0751638460465921, "beta_1": 1.6392724335095241, "drawup_1": 1.5486725887776869, "natr_1": 13.1636646892952, "sup_1": -0.04508391396549289, "res_1": 0.735731442377784, "bullPattern_1": ["3OUTSIDE"], "bearPattern_1": [], "rsi_1": 31.417625314389763, "adx_1": 50.90666026600547, "drawdown_1": -0.674768538064794, "stratHoldSharpe_1": -0.5047437854124287, "stratHoldAlpha_1": 250.66239198095423, "stratHoldDrawdown_1": -0.6216824853904359, "alpha_3mo": -0.9341137630261321, "beta_3mo": 1.6746417617538825, "drawup_3mo": 0.256227773406299, "natr_3mo": 13.1636646892952, "sup_3mo": -0.01630693933245266, "res_3mo": 0.1673861076131617, "bullPattern_3mo": [], "bearPattern_3mo": ["SPINNINGTOP"], "rsi_3mo": 65.13760906007971, "adx_3mo": 43.69250861762582, "drawdown_3mo": -0.4781801627958294, "stratHoldSharpe_3mo": -1.7676412252966063, "stratHoldAlpha_3mo": 249.93257499853644, "stratHoldDrawdown_3mo": -0.43476224768780725, "Country": "United States", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "IPO Year": 2018.0, "Name": "Allogene Therapeutics Inc.", "Sector": "Health Care", "Market Cap": 990723758, "alpha%_1": 0.581310489531036, "beta%_1": 0.8984843308134765, "drawup%_1": 0.9992024061159992, "natr%_1": 0.9999197392207527, "drawdown%_1": 0.08249426349965955, "stratHoldSharpe%_1": 0.25132314685616214, "stratHoldAlpha%_1": 0.11460878879511777, "stratHoldDrawdown%_1": 0.07702514090262955, "alpha%_3mo": 0.058888063878762685, "beta%_3mo": 0.8922251880648596, "drawup%_3mo": 0.4839360149956618, "natr%_3mo": 0.9999088859728226, "drawdown%_3mo": 0.0016046481602799408, "stratHoldSharpe%_3mo": 0.019695159986826232, "stratHoldAlpha%_3mo": 0.007339489465439862, "stratHoldDrawdown%_3mo": 0.0016675853522825942}